台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.35
  • 漲跌
    ▼0.30
  • 漲幅
    -1.05%
  • 成交量
    1,105
  • 產業
    上市 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
神隆 (1789)籌碼相關-富邦-木柵 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-木柵 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/04/2500.00126.0025.90-1409-0.24%
2019/04/22426.2500.0026.1544280.93%
2019/04/1900.00426.2526.25-4436-0.92%
2019/04/091026.3500.0026.55105521.81%
2019/03/2100.000.526.4026.40-0.5520-0.09%
2019/03/19226.5500.0026.3025180.39%
2019/03/1800.002126.5126.40-21515-4.07%
2019/03/15926.6100.0026.5095141.75%
2019/03/12927.0500.0027.0095261.71%
2019/03/11626.81627.3027.2005390.00%
2019/03/04627.35627.2027.1005500.00%
2019/02/2600.00627.2027.20-6564-1.06%
2019/02/1900.001027.7027.75-10672-1.49%
2019/01/2800.00626.8026.80-6658-0.91%
2019/01/24627.6600.0027.1566630.90%
2019/01/1700.00126.4026.40-1682-0.15%
2019/01/14327.70327.8227.1006810.00%
2019/01/11127.0000.0027.3516760.15%
2019/01/10127.65227.8527.20-1670-0.15%
2019/01/0900.00727.4527.35-7657-1.06%
2019/01/081427.51827.2727.3066420.93%
2019/01/071227.402327.3527.10-11628-1.75%
2019/01/04326.50326.6726.4506050.00%
2018/12/201024.6000.0024.10106191.62%
2018/12/11225.2000.0025.1026390.31%
2018/12/10225.0500.0025.0526410.31%
2018/12/0700.00225.6525.50-2646-0.31%
2018/12/061725.8400.0025.20176502.62%
2018/12/03227.0500.0027.0526420.31%
2018/11/30727.0500.0026.9576431.09%
2018/11/291026.9500.0026.90106411.56%
2018/11/2800.00127.0027.10-1639-0.16%
2018/11/2100.001127.1127.00-11609-1.80%
2018/11/20827.012927.3327.00-21590-3.56%
2018/11/091024.0000.0024.10105101.96%
2018/11/021523.1300.0023.10155102.94%
2018/10/3100.000.223.0022.80-0.2509-0.04%
2018/10/26322.27822.2922.55-5524-0.95%
2018/10/1700.00125.8525.40-1493-0.20%
2018/10/121424.881425.0825.2004830.00%
2018/10/11127.10127.3526.3504630.00%
2018/09/27230.5500.0030.3024610.43%
2018/09/2000.00131.4530.80-1463-0.22%
2018/09/19331.60331.3331.3004630.00%
2018/09/03231.0000.0030.9524940.40%
2018/08/3100.003531.1031.15-35501-6.98%
2018/08/30331.2000.0031.2035050.59%
2018/08/2000.003031.0030.90-30611-4.90%
2018/08/17331.3000.0031.4536220.48%
2018/08/16531.5000.0031.2556700.75%
2018/08/101032.2800.0032.00106671.50%
2018/08/09032.2000.0032.4006660.00%
2018/08/0700.00132.8032.85-1675-0.15%
2018/08/0300.00732.5432.35-7667-1.05%
2018/07/31131.9500.0031.9016560.15%
2018/07/23732.1500.0031.8576471.08%
2018/07/201332.4100.0032.45136502.00%
2018/07/19432.7600.0032.8546540.61%
2018/07/181932.7700.0033.15196622.87%
2018/07/17932.8200.0033.0596651.35%
2018/06/21232.6000.0032.7028120.25%
2018/06/2000.00232.9032.70-2820-0.24%
2018/06/15333.1000.0032.4038250.36%
2018/06/12233.7000.0033.7028050.25%
2018/06/0700.001.833.9733.90-1.8798-0.23%
2018/06/01134.3000.0033.9517780.13%
2018/05/3100.00133.6034.20-1759-0.13%
2018/05/28133.0500.0032.8517330.14%
2018/05/09431.5300.0031.5547770.51%
2018/04/1600.00133.6033.30-1958-0.10%
2018/04/09134.9000.0034.9019900.10%
2018/03/30534.24534.3534.0509640.00%
2018/03/29633.75633.8533.9009440.00%
2018/03/21133.15132.9032.9009050.00%
2018/03/1900.000.133.0032.95-0.1906-0.01%
2018/03/141032.731032.8732.9009260.00%
2018/03/1300.00132.6532.65-1926-0.11%
2018/03/0900.00132.7032.60-1945-0.11%
2018/03/08132.0500.0032.5019670.10%
2018/03/0700.00232.2532.05-2967-0.21%
2018/03/0600.00531.7931.70-5972-0.51%
2018/03/05131.4000.0031.4519780.10%
2018/03/02231.5500.0031.8029800.20%
2018/02/26332.5700.0032.5039860.30%
2018/02/2200.00232.7332.85-2997-0.20%
2018/02/091831.141831.3531.6001,0380.00%
2018/02/02134.8000.0034.7011,2870.08%
2018/01/29135.1000.0035.1011,3530.07%
2018/01/24134.9500.0034.9511,3410.07%
2018/01/23135.2500.0035.2011,3310.08%
2018/01/1700.00135.5535.60-11,338-0.07%
2018/01/163136.525136.1236.05-201,330-1.50%
2018/01/152336.293336.6036.70-101,297-0.77%
2018/01/1000.00135.5035.40-11,234-0.08%
2018/01/09236.05135.7535.7011,2290.08%
2018/01/0800.00135.5035.65-11,222-0.08%
2018/01/051035.6000.0035.70101,2160.82%
2018/01/04535.8500.0035.8551,2120.41%
2018/01/032735.5700.0035.50271,2062.24%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章